These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31133636)

  • 81. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection.
    Shiloh MU; Manzanillo P; Cox JS
    Cell Host Microbe; 2008 May; 3(5):323-30. PubMed ID: 18474359
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Dynamic post-translational modification profiling of
    Budzik JM; Swaney DL; Jimenez-Morales D; Johnson JR; Garelis NE; Repasy T; Roberts AW; Popov LM; Parry TJ; Pratt D; Ideker T; Krogan NJ; Cox JS
    Elife; 2020 Jan; 9():. PubMed ID: 31951200
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages.
    Portevin D; Gagneux S; Comas I; Young D
    PLoS Pathog; 2011 Mar; 7(3):e1001307. PubMed ID: 21408618
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Tryptophan biosynthesis protects mycobacteria from CD4 T-cell-mediated killing.
    Zhang YJ; Reddy MC; Ioerger TR; Rothchild AC; Dartois V; Schuster BM; Trauner A; Wallis D; Galaviz S; Huttenhower C; Sacchettini JC; Behar SM; Rubin EJ
    Cell; 2013 Dec; 155(6):1296-308. PubMed ID: 24315099
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The In Vitro M1/M2 Polarization of Macrophages of BCG-Infected Mice.
    Il'in DA; Shkurupy VA
    Bull Exp Biol Med; 2020 Aug; 169(4):467-469. PubMed ID: 32910376
    [TBL] [Abstract][Full Text] [Related]  

  • 86. CRISPR Interference Reveals That All-
    Babunovic GH; DeJesus MA; Bosch B; Chase MR; Barbier T; Dickey AK; Bryson BD; Rock JM; Fortune SM
    mBio; 2022 Feb; 13(1):e0368321. PubMed ID: 35038923
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Gran1: A Granulysin-Derived Peptide with Potent Activity against Intracellular
    Noschka R; Wondany F; Kizilsavas G; Weil T; Weidinger G; Walther P; Michaelis J; Stenger S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445098
    [TBL] [Abstract][Full Text] [Related]  

  • 88. IL-32 is a molecular marker of a host defense network in human tuberculosis.
    Montoya D; Inkeles MS; Liu PT; Realegeno S; Teles RM; Vaidya P; Munoz MA; Schenk M; Swindell WR; Chun R; Zavala K; Hewison M; Adams JS; Horvath S; Pellegrini M; Bloom BR; Modlin RL
    Sci Transl Med; 2014 Aug; 6(250):250ra114. PubMed ID: 25143364
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Infection biology of a novel alpha-crystallin of Mycobacterium tuberculosis: Acr2.
    Wilkinson KA; Stewart GR; Newton SM; Vordermeier HM; Wain JR; Murphy HN; Horner K; Young DB; Wilkinson RJ
    J Immunol; 2005 Apr; 174(7):4237-43. PubMed ID: 15778386
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Downregulation of GPR183 on infection restricts the early infection and intracellular replication of mycobacterium tuberculosis in macrophage.
    Tang J; Shi Y; Zhan L; Qin C
    Microb Pathog; 2020 Aug; 145():104234. PubMed ID: 32353576
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Uncovering complex molecular networks in host-pathogen interactions using systems biology.
    Peters JM; Solomon SL; Itoh CY; Bryson BD
    Emerg Top Life Sci; 2019 Aug; 3(4):371-378. PubMed ID: 33523202
    [TBL] [Abstract][Full Text] [Related]  

  • 92. mSphere of Influence: the Complexity of Interferon Gamma-Mediated Pathogen Control.
    Bryson BD
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33408238
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Mining for humoral correlates of HIV control and latent reservoir size.
    Das J; Devadhasan A; Linde C; Broge T; Sassic J; Mangano M; O'Keefe S; Suscovich T; Streeck H; Irrinki A; Pohlmeyer C; Min-Oo G; Lin S; Weiner JA; Cihlar T; Ackerman ME; Julg B; Deeks S; Lauffenburger DA; Alter G
    PLoS Pathog; 2020 Oct; 16(10):e1008868. PubMed ID: 33048992
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival.
    Atyeo C; Fischinger S; Zohar T; Slein MD; Burke J; Loos C; McCulloch DJ; Newman KL; Wolf C; Yu J; Shuey K; Feldman J; Hauser BM; Caradonna T; Schmidt AG; Suscovich TJ; Linde C; Cai Y; Barouch D; Ryan ET; Charles RC; Lauffenburger D; Chu H; Alter G
    Immunity; 2020 Sep; 53(3):524-532.e4. PubMed ID: 32783920
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques.
    Winchell CG; Mishra BB; Phuah JY; Saqib M; Nelson SJ; Maiello P; Causgrove CM; Ameel CL; Stein B; Borish HJ; White AG; Klein EC; Zimmerman MD; Dartois V; Lin PL; Sassetti CM; Flynn JL
    Front Immunol; 2020; 11():891. PubMed ID: 32477361
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mutations in dnaA and a cryptic interaction site increase drug resistance in Mycobacterium tuberculosis.
    Hicks ND; Giffen SR; Culviner PH; Chao MC; Dulberger CL; Liu Q; Stanley S; Brown J; Sixsmith J; Wolf ID; Fortune SM
    PLoS Pathog; 2020 Nov; 16(11):e1009063. PubMed ID: 33253310
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Leveraging Uncertainty in Machine Learning Accelerates Biological Discovery and Design.
    Hie B; Bryson BD; Berger B
    Cell Syst; 2020 Nov; 11(5):461-477.e9. PubMed ID: 33065027
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Intrabacterial lipid inclusions in mycobacteria: unexpected key players in survival and pathogenesis?
    Mallick I; Santucci P; Poncin I; Point V; Kremer L; Cavalier JF; Canaan S
    FEMS Microbiol Rev; 2021 Nov; 45(6):. PubMed ID: 34036305
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Mycobacterium tuberculosis effector PPE36 attenuates host cytokine storm damage via inhibiting macrophage M1 polarization.
    Gong Z; Han S; Liang T; Zhang H; Sun Q; Pan H; Wang H; Yang J; Cheng L; Lv X; Yue Q; Fan L; Xie J
    J Cell Physiol; 2021 Nov; 236(11):7405-7420. PubMed ID: 33959974
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease.
    Pollara G; Turner CT; Rosenheim J; Chandran A; Bell LCK; Khan A; Patel A; Peralta LF; Folino A; Akarca A; Venturini C; Baker T; Ecker S; Ricciardolo FLM; Marafioti T; Ugarte-Gil C; Moore DAJ; Chain BM; Tomlinson GS; Noursadeghi M
    Sci Transl Med; 2021 May; 13(592):. PubMed ID: 33952677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.